Creo Medical Limited (CREO.L)
CREO.L Stock Price Chart
Explore Creo Medical Limited interactive price chart. Choose custom timeframes to analyze CREO.L price movements and trends.
CREO.L Company Profile
Discover essential business fundamentals and corporate details for Creo Medical Limited (CREO.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
9 Dec 2016
Employees
278.00
Website
https://creomedical.comCEO
Craig Jonathan Gulliford
Description
Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was incorporated in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.
CREO.L Financial Timeline
Browse a chronological timeline of Creo Medical Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 18 May 2026
Upcoming earnings on 29 Sept 2025
Earnings released on 19 May 2025
Earnings released on 30 Sept 2024
EPS came in at -£0.03, while revenue for the quarter reached £15.20M.
Earnings released on 15 May 2024
EPS came in at -£0.03, while revenue for the quarter reached £15.10M, missing expectations by -16.91%.
Earnings released on 12 Sept 2023
EPS came in at -£0.04, while revenue for the quarter reached £15.70M, meeting expectations.
Earnings released on 26 Apr 2023
EPS came in at -£0.07, while revenue for the quarter reached £13.53M, missing expectations by -2.63%.
Stock split effective on 16 Feb 2023
Shares were split 259:250, changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Jun 2022
EPS came in at -£0.07, while revenue for the quarter reached £13.64M, meeting expectations.
Earnings released on 31 Dec 2021
EPS came in at -£0.08, while revenue for the quarter reached £12.26M.
Earnings released on 30 Jun 2021
EPS came in at -£0.06, while revenue for the quarter reached £12.90M.
Earnings released on 31 Dec 2020
EPS came in at -£0.07, while revenue for the quarter reached £9.43M.
CREO.L Stock Performance
Access detailed CREO.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.